KA-1783

N/A

Report date: 2025/06/11 11:23:54

Base Information

Drug NameKA-1783
Drug Alias NameTreg-depleting anti-CD25 humanized antibody (Kyinno Biotechnology)H11E11-2V1KA-1783
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin-2 receptor alpha chain modulatorsImmunostimulantsRegulatory T-lymphocytes inhibitors
TargetsInterleukin-2 receptor alpha chain
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKYinno Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKYinno Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A